Literature DB >> 19877293

What does the long-term liver allograft look like for the pediatric recipient?

Stefan Hübscher1.   

Abstract

1. Histological abnormalities are commonly present in late posttransplant biopsies from pediatric liver allograft recipients. 2. Many of the changes are seen in children who appear to be clinically well with good graft function. 3. In comparison with adults, children may be more prone to developing late rejection (possibly related to noncompliance with immunosuppression) and biliary/vascular complications, but they are much less likely to suffer problems with disease recurrence. 4. De novo autoimmune hepatitis occurs in 5% to 10% of children after transplantation and may represent a hepatitic form of late cellular rejection. Most cases respond to treatment with increased immunosuppression. 5. Recent studies have shown a high frequency of unexplained (idiopathic) chronic hepatitis in late posttransplant biopsies from children. This is associated with the development of graft fibrosis and cirrhosis. 6. Further studies are required to investigate the role of protocol liver biopsies in determining therapeutic strategies in children who appear to have good graft function according to noninvasive investigations. (c) 2009 AASLD.

Entities:  

Mesh:

Year:  2009        PMID: 19877293     DOI: 10.1002/lt.21902

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  10 in total

Review 1.  Enhancing the Value of Histopathological Assessment of Allograft Biopsy Monitoring.

Authors:  Michelle A Wood-Trageser; Andrew J Lesniak; Anthony J Demetris
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

2.  Protocol liver biopsy is the only examination that can detect mid-term graft fibrosis after pediatric liver transplantation.

Authors:  Yukihiro Sanada; Koshi Matsumoto; Taizen Urahashi; Yoshiyuki Ihara; Taiichi Wakiya; Noriki Okada; Naoya Yamada; Yuta Hirata; Koichi Mizuta
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

3.  Acoustic radiation force impulse (ARFI) elastography for the noninvasive diagnosis of liver fibrosis in children.

Authors:  Sylviane Hanquinet; Anne-Laure Rougemont; Delphine Courvoisier; Laura Rubbia-Brandt; Valérie McLin; Michela Tempia; Mehrak Anooshiravani
Journal:  Pediatr Radiol       Date:  2012-12-28

4.  Pediatric liver transplantation for primary sclerosing cholangitis.

Authors:  Tamir Miloh; Ravinder Anand; Wendy Yin; Miriam Vos; Nanda Kerkar; Estella Alonso
Journal:  Liver Transpl       Date:  2011-08       Impact factor: 5.799

5.  Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.

Authors:  Ye H Oo; Stefan G Hubscher; David H Adams
Journal:  Hepatol Int       Date:  2010-05-19       Impact factor: 6.047

6.  Clinical Value of Surveillance Biopsies in Pediatric Liver Transplantation.

Authors:  Brittany Rocque; Aaron Zaldana; Carly Weaver; Julia Huang; Arianna Barbetta; Victoria Shakhin; Cameron Goldbeck; George Yanni; Shannon Zielsdorf; Yong Kwon; Kambiz Etesami; Yuri Genyk; Shengmei Zhou; Rohit Kohli; Juliet Emamaullee
Journal:  Liver Transpl       Date:  2022-01-20       Impact factor: 6.112

Review 7.  Not only a small liver - The pathologist's perspective in the pediatric liver transplant setting.

Authors:  Alessandro Gambella; Luca Mastracci; Chiara Caporalini; Paola Francalanci; Claudia Mescoli; Jacopo Ferro; Rita Alaggio; Federica Grillo
Journal:  Pathologica       Date:  2022-02

Review 8.  Long-term liver allograft fibrosis: A review with emphasis on idiopathic post-transplant hepatitis and chronic antibody mediated rejection.

Authors:  Mukul Vij; Ashwin Rammohan; Mohamed Rela
Journal:  World J Hepatol       Date:  2022-08-27

9.  Histopathological causes of late liver allograft dysfunction: analysis at a single institution.

Authors:  Eun Shin; Ji Hoon Kim; Eunsil Yu
Journal:  Korean J Pathol       Date:  2013-02-25

Review 10.  Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies.

Authors:  Xiaoxiao Du; Sheng Chang; Wenzhi Guo; Shuijun Zhang; Zhonghua Klaus Chen
Journal:  Front Immunol       Date:  2020-06-24       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.